Loading...

Loading...

The Global Cancer Burden and the Outlook for Latin America
By Guillaume Corpart - Mon, 12/15/2025 - 06:00
The outlook on cancer, both worldwide and in Latin America, is a complex story that includes both good news and bad news. Guillaume Corpart explains.
https://mexicobusiness.news/tag/chemotherapy
More Health
Breast Cancer Recovery: The Essential Role of Reconstruction
By Víctor Matos - Tue, 11/04/2025 - 08:30
Breast cancer survivorship requires physical and emotional reconstruction, improving mental health and quality of life, writes Víctor Matos.
Advances in Multiple Myeloma Care Extend Patient Survival
By MBN Staff - Thu, 09/04/2025 - 15:20
Medical advances and hospital infrastructure in Mexico improve multiple myeloma treatment, extending patient survival beyond 10 years.
Mexico Joins Growing Market for Metastatic Cancer Therapeutics
By MBN Staff - Wed, 07/02/2025 - 10:58
Mexico is part of the expanding metastatic cancer therapeutics market, driven by rising cases and advances in drug approvals and treatments.
INCan Highlights Progress in Blood Cancer Therapies
By MBN Staff - Mon, 06/09/2025 - 09:52
New therapies are improving outcomes for blood cancer patients in Mexico, with INCan emphasizing early detection and modern treatment options.
World Ovarian Cancer Day Highlights Early Detection Urgency
By Aura Moreno - Wed, 05/14/2025 - 11:21
Ovarian cancer remains hard to detect early, but prompt diagnosis and access to care can significantly improve survival rates.
Managing Cancer Through Molecular Expertise, Technology
By Sofía Garduño - Wed, 01/08/2025 - 12:45
Cancer care requires a multidisciplinary approach that incorporates genomics, molecular biology, and clinical expertise, says Theranomics’ Luis Velez.
Pfizer’s BRAFTOVI Regimen Approved for Metastatic CRC
By MBN Staff - Mon, 12/23/2024 - 13:39
Pfizer's BRAFTOVI, combined with cetuximab and mFOLFOX6, is FDA-approved for treating metastatic colorectal cancer with a BRAF V600E mutation.
FDA Approves Vyloy for Advanced Gastric Cancer Treatment
By MBN Staff - Wed, 10/23/2024 - 08:51
The FDA approved Astellas' Vyloy for advanced gastric cancer, targeting cancer cells and improving survival with chemotherapy.
AstraZeneca's Truqap Fails in Breast Cancer Trial
By MBN Staff - Wed, 06/19/2024 - 09:37
AstraZeneca's combination of Truqap and paclitaxel fails to meet primary objectives in a late-stage trial for triple-negative breast cancer.